Try our beta test site

Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by Shanghai Zerun Biotechnology Co.,Ltd.
Recruitment status was:  Enrolling by invitation
Sponsor:
Information provided by (Responsible Party):
Shanghai Zerun Biotechnology Co.,Ltd
ClinicalTrials.gov Identifier:
NCT01548118
First received: February 29, 2012
Last updated: March 5, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)